Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCOS.L Regulatory News (COS)

  • There is currently no data for COS

Conference attendance

1 Mar 2018 07:00

RNS Number : 3044G
Collagen Solutions PLC
01 March 2018
 

 

1 March 2018

Collagen Solutions to Present at Canaccord Genuity Musculoskeletal Conference &

Exhibit at American Academy of Orthopaedic Surgeons Conference

Dates: 6-9 March 2018

 

 

Collagen Solutions Plc (AIM: COS), (the "Company"), the developer and manufacturer of medical grade collagen and tissue components for use in regenerative medicine, including orthopaedic, dental, wound care, and cardiovascular applications, confirms two forthcoming conferences it will be attending in New Orleans, Louisiana, USA, between 6-9 March 2018.

· Jamal Rushdy, CEO, to present at the Canaccord Genuity Musculoskeletal Conference (6 March)· Company to Exhibit at the American Academy of Orthopaedic Surgeons "AAOS" Annual Conference (7-9 March)

 

AAOS is the world's largest and most prestigious annual orthopaedic meeting so attending this conference and presenting at the accompanying Canaccord Genuity Musculoskeletal Conference provides access to an extremely wide range of investors and manufacturers in areas of spine, trauma/extremities, foot and ankle, and sports medicine.

 

Commenting on the conferences, Jamal Rushdy, CEO said: "We are pleased to have the opportunity to present at the Canaccord Genuity Musculoskeletal Conference, where we will highlight our recently announced positive 8-year follow-on data from ChondroMimetic® demonstrating durable cartilage regeneration in keyhole knee surgery. We are also excited to be a first-time exhibitor at AAOS and to showcase our OEM capabilities and propriety device licensing opportunities to investors and industry partners. These meetings provide the opportunity to actively engage with orthopaedic companies on a global scale. We will also be providing hands-on demonstrations of prototypes for our Bone Graft Substitute, ChondroMimetic® Cartilage Repair Scaffold, and Fibrillar Collagen development programmes."

 

 

 

Collagen Solutions PlcJamal Rushdy, Chief Executive OfficerHilary Spence, Chief Financial OfficerLisa Baderoon, Head of Investor Relations

Tel: +44 (0) 141 648 9100Tel: +44 (0) 7721 413 496 or lisa.baderoon@collagensolutions.com

Cenkos Securities plc (NOMAD and Broker)Stephen KeysSteve Cox

Tel: +44 (0) 207 397 8900

Walbrook PRAnna DunphyHelen Cresswell

Tel: +44 (0) 20 7933 8780 or collagen@walbrookpr.comMob: +44 (0) 7876 741 001

 

About Collagen Solutions:

Collagen Solutions Plc is a global supplier, developer, and manufacturer of medical grade collagen, tissues, and related medical devices and components for use in regenerative medicine, medical devices and in-vitro diagnostics and research. The Company is also expanding its range of biomaterials-based finished medical devices based on its internal and acquired intellectual property for commercialisation with partners via licensing and distribution arrangements, including ChondroMimetic®. The Company's products are used in a wide variety of applications including orthopaedics, cardiovascular, dental, plastic surgery, wound healing, neurology and urology.

For more information go to: www.collagensolutions.com

The American Academy of Orthopedic Surgeons (AAOS)

AAOS is an orthopedic organisation. Founded at Northwestern University in 1933, as of 2015 AAOS had grown to include about 39,000 members. The group provides education and practice management services for orthopedic surgeons and allied health professionals. The AAOS also lobbies and works on public education. The AAOS describes itself as "the world's largest medical association of musculoskeletal specialists.

For more information go to: www.aaos.org

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAZMGZZNRFGRZM
Date   Source Headline
30th Aug 201711:21 amRNSResult of AGM
30th Aug 20177:00 amRNSAGM Statement
26th Jul 20177:00 amRNSPosting of Annual Report & notice of AGM
25th Jul 201711:36 amRNSDirector/PDMR Shareholding
25th Jul 20177:15 amRNSHardman Research: Transition to sustainable growth
13th Jul 201711:39 amRNSDirector/PDMR Shareholding
11th Jul 20177:00 amRNSFinal Results
7th Jul 20177:00 amRNSFirst patient enrolment in ChondroMimetic® study
19th Jun 20177:00 amRNSNotice of Results
13th Jun 20177:00 amRNSProvisional patent submitted
11th May 20177:15 amRNSHardman Research: Trading:earnings above forecasts
25th Apr 20177:00 amRNSTrading Update
24th Apr 20177:00 amRNSConsolidation of US R&D activities & Board change
10th Apr 20177:00 amRNSCollagen Based Spray Adhesive Poster Presented
3rd Apr 201711:22 amRNSHolding(s) in Company
3rd Apr 20177:00 amRNSAgreement signed with Smart Matrix Limited
31st Mar 20174:52 pmRNSHolding(s) in Company
29th Mar 20177:00 amRNSPericardium Divisional Patent in Australia
27th Mar 201712:39 pmRNSDirector/PDMR Shareholding
24th Mar 20179:26 amRNSDirector/PDMR Shareholding
23rd Mar 20177:00 amRNSAttending UK Investor Show
20th Mar 20178:56 amRNSIntroduces new online sales initiative in the US
15th Mar 20179:58 amRNSHolding(s) in Company
14th Mar 20173:28 pmRNSHolding(s) in Company
13th Mar 201711:52 amRNSHardman Research: Engineering cartilage repairs
13th Mar 20179:57 amRNSHolding(s) in Company
13th Mar 20177:05 amRNSHardman Research: Engineering cartilage repairs
9th Mar 20177:00 amRNSHolding(s) in Company
9th Mar 20177:00 amRNSHolding(s) in Company
9th Mar 20177:00 amRNSAttending AAOS and ORS meetings in San Diego
8th Mar 20177:00 amRNSDirector/PDMR Shareholding
7th Mar 20174:08 pmRNSHolding(s) in Company
7th Mar 20171:01 pmRNSDirector/PDMR Shareholding
7th Mar 201711:19 amRNSHolding(s) in Company
7th Mar 20179:56 amRNSHolding(s) in Company
6th Mar 20172:24 pmRNSResult of General Meeting
20th Feb 20177:00 amRNSInvestor presentation
15th Feb 201711:29 amRNSGrant of Options
14th Feb 201711:24 amRNSHardman Research: Funding accelerated growth
14th Feb 20177:00 amRNSPlacing Open Offer and Debt Financing
7th Feb 20177:00 amRNSAttends MD&M West Conference in Anaheim
19th Jan 20177:00 amRNSNew Scientific Advisory Board appointments
13th Jan 20177:00 amRNSThird Medical Research Scotland Ph.D. Studentship
21st Dec 201612:06 pmRNSHardman Research: Foundations for strategic growth
19th Dec 20167:00 amRNSHalf-year Report
14th Dec 20167:00 amRNSPoster Presentation at TERMIS-AM
2nd Dec 20167:00 amRNSNotice of Results
13th Oct 20167:00 amRNSTrading Statement
3rd Oct 20167:00 amRNSChange of Adviser
15th Sep 20167:00 amRNSParticipation in major Horizon 2020 project

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.